1. 1 Xavier University of Louisiana College of Pharmacy Curriculum Map – NAPLEX Competencies Map by Competency

2. 2 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.1 – Identify and assess patient information including medication, laboratory and disease state histories. CourseCBCOTeaching method(s) Assessment method(s) DSM - I ILT BiopharmaceuticsIL HW, T PharmacyPracticeECSLab DSM – II R, E L, VT, CS, O T, IGP IPPE – III R SGD, O OP, IGP Clinical Rotation R, E SGD, O, CS OP, IGP, T, Q, D, O

3. 3 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.2 – Identify and/or use instruments and techniques related to patient assessment and diagnosis. CourseCBCO Teaching method(s) Assessment method(s) PathophysiologyI L, CS T DSM – I ILT PharmacyPracticeE VT, CS, GS OP, IGP, Lab, D DSM – II RL? DSM – III I, E L, CS T, IGP

4. 4 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.2 – Identify and/or use instruments and techniques related to patient assessment and diagnosis. CourseCBCO Teaching method(s) Assessment method(s) IPPE – III E SGD, O OP Clinical Rotation R, E SGD, OP, O, CS OP, IGP, Q, D

5. 5 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.3 – Identify and define the terminology, signs and symptoms associated with diseases and medical conditions. CourseCBCO Teaching method(s) Assessment method(s) BiochemistryILT Med. Chem. I ILT PathophysiologyI CS, L T DSM – I ILT Med. Chem. II RLT

6. 6 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.3 – Identify and define the terminology, signs and symptoms associated with diseases and medical conditions. CourseCBCO Teaching method(s) Assessment method(s) DSM – II RLT DSM – III I, E L, CS, O T, IGP IPPE – III E SGD, O IGP, OP Clinical Rotation R SGD, CS, O OP, IGP, O

7. 7 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.4 – Identify and evaluate patient factors, genetic factors, biosocial factors, and concurrent drug therapy that are relevant to the maintenance of wellness and the prevention or treatment of a disease or medical condition. CourseCBCO Teaching method(s) Assessment method(s) Med. Chem. I ILT DSM – I ILT BiopharmaceuticsIL HW, T PharmacyPracticeECSLab

8. 8 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.4 – Identify and evaluate patient factors, genetic factors, biosocial factors, and concurrent drug therapy that are relevant to the maintenance of wellness and the prevention or treatment of a disease or medical condition. CourseCBCO Teaching method(s) Assessment method(s) DSM – II RLT DSM – III I, E L, VT, CS, O T, IGP IPPE – III RSGD O,OP, IGP Clinical Rotation I, R, E SGD, CS, O OP, Q, IGP, O

9. 9 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.1 – Identify specific uses and indications for drug products. CourseCBCO Teaching method(s) Assessment method(s) BiochemistryILT PharmaceuticsI?? Med. Chem. I ILT DSM – I ILT Med. Chem. II ILT BiopharmaceuticsRL HW, T

10. 10 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.1 – Identify specific uses and indications for drug products. CourseCBCO Teaching method(s) Assessment method(s) Pharmacy Practice ECS Q, OP, IGP, Lab DSM – II RLT DSM – III R, E L, CS, O T, IGP IPPE – III RSGD IGP, OP Clinical Rotation R, E SGD, CS, O T, Q, OP, HW, IGP, D

11. 11 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.2 – Identify the known or postulated sites and mechanisms of action of pharmacotherapeutic agents. CourseCBCO Teaching method(s) Assessment method(s) Principles of Drug Action IL T, Q Med. Chem. I ILT P. Sciences Lab I, R L IGP, Lab, D, T DSM – I RLT Med. Chem. II ILT

12. 12 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.2 – Identify the known or postulated sites and mechanisms of action of pharmacotherapeutic agents. CourseCBCO Teaching method(s) Assessment method(s) Pharmacy Practice ECS Q, OP, IGP, Lab DSM – II RLT DSM – III R, E L, VT, CS, O T, IGP IPPE – III R SGD, O OP, IGP Clinical Rotation R, E CS, SGD, O Q, T, OP, D

13. 13 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.3 –Evaluate drug therapy for the presence of pharmacotherapeutic duplications and interactions with other drugs, food, diagnostic tests, and monitoring procedures. CourseCBCO Teaching method(s) Assessment method(s) Med. Chem. I ILT DSM – I ICS? Pharmacy Practice ECS OP, HW, IGP, Lab DSM – II RLT DSM – III I, E L, CS T, IGP

14. 14 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.3 –Evaluate drug therapy for the presence of pharmacotherapeutic duplications and interactions with other drugs, food, diagnostic tests, and monitoring procedures. CourseCBCO Teaching method(s) Assessment method(s) IPPE – III R SGD, O OP, IGP Clinical Rotation R, E CS, SGD, O Q, RP, P, OP, D

15. 15 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.4 –Identify contraindications, warnings, and precautions associated with a drug product’s active and inactive ingredients. CourseCBCO Teaching method(s) Assessment method(s) Principles of Drug ActionIL T, Q, RP Med. Chem. I ILT DSM – I I L, CS T Med. Chem. II ILT Pharmacy Practice ECS Q, RP, OP, IGP, Lab

16. 16 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.4 –Identify contraindications, warnings, and precautions associated with a drug product’s active and inactive ingredients. CourseCBCO Teaching method(s) Assessment method(s) DSM – II RLT DSM – III R, E L, CS T, IGP IPPE – III R SGD, O IGP, OP Clinical Rotation R, E SGD, CS, O Q, OP, IGP, D

17. 17 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.5 –Identify physiochemical properties of drug substances that affect their solubility, pharmacodynamic and pharmacokinetic properties, pharmacologic actions and stability. CourseCBCO Teaching method(s) Assessment method(s) Principles of Drug ActionIL T, Q, RP Pharmaceutics I IL Lab, T Med. Chem. I I, R LT P. Sciences Lab RL D, Lab, IGP Med. Chem. II I, R LT

18. 18 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.5 –Identify physiochemical properties of drug substances that affect their solubility, pharmacodynamic and pharmacokinetic properties, pharmacologic actions and stability. CourseCBCO Teaching method(s) Assessment method(s) BiopharmaceuticsRLT Pharmacy Practice RCSLab DSM – II RLT Applied Kinetics ILT DSM – III ECSIGP

19. 19 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.5 –Identify physiochemical properties of drug substances that affect their solubility, pharmacodynamic and pharmacokinetic properties, pharmacologic actions and stability. CourseCBCO Teaching method(s) Assessment method(s) IPPE – III R SGD, O OP Clinical Rotation R, E CS,SGD, O Q, D

20. 20 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.6 – Interpret and apply pharmacodynamic and pharmacokinetic principles to calculate and determine appropriate drug dosing regimens. CourseCBCO Teaching method(s) Assessment method(s) Principles of Drug Action IL RP, T, Q P. Sciences Lab RL IGP, Lab, D BiopharmaceuticsIL T, HW, D Pharmacy Practice E L, CS T, Lab DSM – II RLT

21. 21 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.6 – Interpret and apply pharmacodynamic and pharmacokinetic principles to calculate and determine appropriate drug dosing regimens. CourseCBCO Teaching method(s) Assessment method(s) Applied Kinetics ILT DSM – III I, E L, CS T, IGP IPPE – III R O, SGD IGP, OP Clinical Rotation R, E SGD, CS, O Q, OP, D

22. 22 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.7 – Interpret and apply biopharmaceutic principles and the pharmaceutical characteristics of drug dosage forms and delivery systems, to assure bioavailability and enhance patient compliance. CourseCBCO Teaching method(s) Assessment method(s) Principles of Drug ActionIL T, Q, RP Pharmaceutics I I, R L T, Lab BiopharmaceuticsIL HW, T Pharmacy Practice E VT, CS, GS OP, IGP, Lab DSM – II RLT

23. 23 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.7 – Interpret and apply biopharmaceutic principles and the pharmaceutical characteristics of drug dosage forms and delivery systems, to assure bioavailability and enhance patient compliance. CourseCBCO Teaching method(s) Assessment method(s) Applied Kinetics RLT DSM – III ECSIGP IPPE – III RSGDOP Clinical Rotation R, E SGD, CS, O Q, OP, D

24. 24 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.1 – Identify pharmacotherapeutic outcomes and endpoints. CourseCBCO Teaching method(s) Assessment method(s) DSM – I ILT Med. Chem. II ?LT Pharmacy Practice RCS IGP, Lab DSM – II RLT DSM – III I, E CS, L T, IGP

25. 25 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.1 – Identify pharmacotherapeutic outcomes and endpoints. CourseCBCO Teaching method(s) Assessment method(s) IPPE – III RSGDOP Clinical Rotation R, E SGD, O Q, OP, D

26. 26 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.2 – Evaluate patient signs and symptoms, and the results of monitoring tests and procedures to determine the safety and effectiveness of pharmacotherapy. CourseCBCO Teaching method(s) Assessment method(s) DSM – I I L, CS T DSM – II RLT DSM – III I, E L, CS T, IGP IPPE – III R SGD, O OP, IGP Clinical Rotation R, E SGD, O OP, T, Q, D

27. 27 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.3 – Identify, describe the mechanism of, and remedy adverse reactions, allergies, side effects and iatrogenic or drug-induced illness. CourseCBCO Teaching method(s) Assessment method(s) BiochemistryILT Med. Chem. I ILT Med. Chem. II ILT Pharmacy Practice RCSLab DSM – II RLT

28. 28 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.3 – Identify, describe the mechanism of, and remedy adverse reactions, allergies, side effects and iatrogenic or drug-induced illness. CourseCBCO Teaching method(s) Assessment method(s) DSM – III I, E L, CS IGP IPPE – III R O, SGD OP Clinical Rotation R, E SGD, CS, O RP, OP, D

29. 29 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.4 – Prevent, recognize, and remedy medication non-adherence, misuse or abuse. CourseCBCO Teaching method(s) Assessment method(s) DSM – I ILT Pharmacy Practice ECS IGP, Lab DSM – II RLT DSM – III I, E L, CS IGP IPPE – III I O, SGD OP, RP Clinical Rotation R, E SGD, O OP, D

30. 30 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.5 – Recommend pharmacotherapeutic alternatives. CourseCBCO Teaching method(s) Assessment method(s) Med. Chem. I ILT DSM – I I L, CS T Med. Chem. II ILT DSM – II RLT

31. 31 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.5 – Recommend pharmacotherapeutic alternatives. CourseCBCO Teaching method(s) Assessment method(s) DSM – III I, E L, CS T, IGP IPPE – III R SGD, O OP, IGP Clinical Rotation R, E SGD, O OP, T, Q, IGP, D

32. 32 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.1.0 – Perform calculations required to compound, dispense, and administer medication. 2.1.1 – Calculate the quantity of medication to be compounded or dispensed; reduced and enlarge formulation quantities and calculate the quantity of ingredients needed to compound the proper amount of the preparation. CourseCBCO Teaching method(s) Assessment method(s) Pharmaceutics I RL Lab, T Pharmacy Practice ELLab IPPE – III ISGD?

33. 33 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.1.0 – Perform calculations required to compound, dispense, and administer medication. 2.1.2 – Calculate nutritional needs and the caloric content of nutrient sources. CourseCBCO Teaching method(s) Assessment method(s) Pharmacy Practice ECSLab

34. 34 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.1.0 – Perform calculations required to compound, dispense, and administer medication. 2.1.3 – Calculate the rate of drug administration. CourseCBCO Teaching method(s) Assessment method(s) BiopharmaceuticsIL T, Q, HW Pharmacy Practice ECSLab DSM – II RLT Applied Kinetics RLT

35. 35 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.1.0 – Perform calculations required to compound, dispense, and administer medication. 2.1.4 – Calculate or convert drug concentrations, ratio strengths, and/or extent of ionization. CourseCBCO Teaching method(s) Assessment method(s) Pharmaceutics I I, R L T, Lab BiopharmaceuticsRL T, HW Pharmacy Practice E L, CS Lab Applied Kinetics RLT

36. 36 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.1 – Identify drug products by their generic, brand, and/or common names. CourseCBCO Teaching method(s) Assessment method(s) Med. Chem. I ILT DSM – I RLT Med. Chem. II ILT Pharmacy Practice EOQ DSM – II RLT

37. 37 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.1 – Identify drug products by their generic, brand, and/or common names. CourseCBCO Teaching method(s) Assessment method(s) DSM – III RLT Pharmacy Law RLT IPPE – III RSGDOP Clinical Rotation R, E SGD, O T, Q, OP, IGP, O

38. 38 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.2 – Determine whether a particular drug dosage strength or dosage form is commercially available, and whether it is available on a nonprescription basis. CourseCBCO Teaching method(s) Assessment method(s) DSM - I IL? Pharmacy Practice EOQ DSM – II RLT DSM – III RL?

39. 39 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.2 – Determine whether a particular drug dosage strength or dosage form is commercially available, and whether it is available on a nonprescription basis. CourseCBCO Teaching method(s) Assessment method(s) Pharmacy Law RLT IPPE - III RSGDOP Clinical Rotation I, E SGD, O OP, HW, O

40. 40 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.3 – Identify commercially available drug products by their characteristic physical attributes. CourseCBCO Teaching method(s) Assessment method(s) Clinical Rotation E SGD, O OP, O

41. 41 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.4– Interpret and apply pharmacokinetic parameters and quality assurance data to determine equivalence among manufactured drug products, and identify products for which documented evidence of inequivalence exists. CourseCBCO Teaching method(s) Assessment method(s) BiopharmaceuticsIL T, HW Applied Kinetics RLT IPPE – III RSGD? Clinical Rotation EOO

42. 42 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.5 – Identify and communicate appropriate information regarding packaging, storage, handling, administration, and disposal of medications. CourseCBCO Teaching method(s) Assessment method(s) Principles of Drug Action IL RP, Q, T DSM – I IL? BiopharmaceuticsRL T, HW Pharmacy Practice EOQ

43. 43 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.5 – Identify and communicate appropriate information regarding packaging, storage, handling, administration, and disposal of medications. CourseCBCO Teaching method(s) Assessment method(s) Pharmacy Law ELT IPPE – III ISGD? Clinical Rotation I, E SGD,O OP, D, O

44. 44 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.6 – Identify and describe the use of equipment and apparatus required to administer medications. CourseCBCO Teaching method(s) Assessment method(s) CalculationsIL T, Q, HW DSM – I IL? Pharmacy Practice ECS Q, OP, IGP, D, O Applied Kinetics ILT IPPE – III ISGDO Clinical Rotation E SGD, O O

45. 45 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.3.0 – Prepare and compound extemporaneous preparations and sterile products. 2.3.1 – Identify and describe techniques and procedures related to drug preparation, compounding and quality assurance. CourseCBCO Teaching method(s) Assessment method(s) Pharmaceutics I EL T, Lab Rsch. & Lit. Eval. I EL T, RP Pharmacy Law RLT IPPE – III IGS?

46. 46 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.3.0 – Prepare and compound extemporaneous preparations and sterile products. 2.3.2 – Identify and use equipment necessary to prepare and extemporaneously compound medications. CourseCBCO Teaching method(s) Assessment method(s) CalculationsIL HW, T, Q Pharmaceutics I EL T, Lab IPPE – III IGS?

47. 47 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.3.0 – Prepare and compound extemporaneous preparations and sterile products. 2.3.3 – Identify the important physiochemical properties of a preparation’s active and inactive ingredients; describe the mechanism of, and the characteristic evidence of incompatibility or degradation; and identify methods for achieving stabilization of the preparation CourseCBCO Teaching method(s) Assessment method(s) BiochemistryILT Principles of Drug Action IL T, Q,RP Pharmaceutics I I, R L T, Lab Med. Chem. I I, R LT

48. 48 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.3.0 – Prepare and compound extemporaneous preparations and sterile products. 2.3.3 – Identify the important physiochemical properties of a preparation’s active and inactive ingredients; describe the mechanism of, and the characteristic evidence of incompatibility or degradation; and identify methods for achieving stabilization of the preparation CourseCBCO Teaching method(s) Assessment method(s) P. Sciences Lab RL D, Lab, IGP Med. Chem. II ILT IPPE – III IGS?

49. 49 Area 3 - Provide Health Care Information and Promote Public Health 3.1.0 – Access, evaluate, and apply information to promote optimal health care. 3.1.1 – Identify the typical content and organization of specific sources of drug and health information for both health care providers and consumers. CourseCBCO Teaching method(s) Assessment method(s) PSL – I I L, SGD, O RP, P, OP, HW, IGP IPPE – III ISGDIGP Clinical Rotation I, R, E O, SGD OP, O

50. 50 Area 3 - Provide Health Care Information and Promote Public Health 3.1.0 – Access, evaluate, and apply information to promote optimal health care. 3.1.2 – Evaluate the suitability, accuracy, and reliability of information from reference sources by explaining and evaluating the adequacy of experimental design and by applying and evaluating statistical test and parameters. CourseCBCO Teaching method(s) Assessment method(s) PSL – I I O, SGD, L IGP, HW, OP, P, RP BiopharmaceuticsRLT IPPE – III ISGD RP, OP, IGP Clinical Rotation R, E O, CS, SGD O, OP

51. 51 Area 3 - Provide Health Care Information and Promote Public Health 3.2.0 – Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.1 – Provide health care information regarding the prevention and treatment of diseases and medical conditions, including emergency patient care. CourseCBCO Teaching method(s) Assessment method(s) Pharmacy Law RLT IPPE – III ISGDIGP Clinical Rotation R, E O, SGD D, HW, OP

52. 52 Area 3 - Provide Health Care Information and Promote Public Health 3.2.0 – Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.2 – Provide health care information regarding nutrition, lifestyle, and other non-drug measures that are effective in promoting health or preventing or minimizing the progression of a disease or medical condition. CourseCBCO Teaching method(s) Assessment method(s) BiochemistryILT Pharmacy Practice RCS OP, IGP Pharmacy Law RLT IPPE – III ISGD? Clinical Rotation R, E SGD, O OP, D

53. 53 Area 3 - Provide Health Care Information and Promote Public Health 3.2.0 – Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.3 – Provide information regarding the documented uses, adverse effects and toxicities of dietary supplements. CourseCBCO Teaching method(s) Assessment method(s) Pharmacy Practice ECS RP, OP, IGP Pharmacy Law RLT IPPE – III ISGD? Clinical Rotation R, E SGD, CS, O OP, IGP, D

54. 54 Area 3 - Provide Health Care Information and Promote Public Health 3.2.0 – Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.4 – Provide information regarding the selection, use and care of medical/surgical appliances and devices, self-care products, and durable medical equipment, as well as products and techniques for self-monitoring of health status and medical conditions. CourseCBCO Teaching method(s) Assessment method(s) Pharmacy Law RLT Clinical Rotation R, E SGD, O OP, D